Related Experiment Video
Updated: Aug 31, 2025
10:16
Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies
Published on: September 15, 2016
12.9K
Development of a protein microarray for profiling circulating autoantibodies in human diseases
Jing Ren1, Hongye Wang2, Chundi Wei2
1School of Basic Medicine Sciences, Anhui Medical University, Hefei, Anhui, PR China.
Proteomics. Clinical Applications
|August 25, 2022
Summary
A new microarray platform detects thousands of autoantibodies (AAbs) simultaneously, offering high sensitivity and reproducibility for disease research. This tool aids in studying autoimmunity and integrating multi-omics data for human disease investigations.
Area of Science:
- Biotechnology
- Immunology
- Diagnostics
Background:
- Autoantibodies (AAbs) are crucial biomarkers for various autoimmune diseases.
- Simultaneous detection of a wide range of AAbs is essential for comprehensive disease profiling.
- Current diagnostic methods may lack the capacity for high-throughput, multiplexed AAb analysis.
Purpose of the Study:
- To develop and validate a robust microarray platform for the simultaneous detection of thousands of serological autoantibodies.
- To establish a sensitive and reproducible method for large-scale AAb profiling in patient serum.
- To demonstrate the utility of the microarray in identifying disease-specific AAb signatures.
Main Methods:
- Preparation of the AAbMap microarray by printing 4032 purified His-tagged human proteins and peptide probes.
- Systematic optimization and validation of the microarray's sensitivity, dynamic range, and reproducibility (intra- and inter-array).
- Large-scale profiling of AAbs in serum samples from healthy controls and patients with rheumatoid arthritis, systemic lupus erythematosus, and lung cancer.
Main Results:
- The AAb microarray demonstrated a high dynamic range (2-3 orders of magnitude) with a low limit of detection (68 pg/mL).
- Exceptional reproducibility was achieved, with intra-array correlation of 1.00 and inter-array correlations of 0.99-0.98.
- Significant numbers of AAbs were detected in patient cohorts, including known disease biomarkers like anti-cyclic citrullinated peptide and anti-nucleosome antibodies.
Conclusions:
- A robust microarray platform capable of simultaneously detecting thousands of serological AAbs with high sensitivity and reproducibility has been developed.
- This AAbMap microarray serves as a valuable tool for advancing the study of autoimmunity.
- The platform facilitates integrated analysis with genomics, proteomics, and metabolomics data for systematic human disease investigation.
